Lilly’s Taltz wins EU approval for psoriatic arthritis
Eli Lilly has been given a green light to market Taltz in the European Union as a treatment for psoriatic arthritis.
Read More
Tag: SPIRIT-P1
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
